摘要
目的建立HBcAg特异性CTL作用的靶细胞系统,为进一步研究HBV基因变异对CTL细胞毒效应的影响奠定基础。方法采用两种质粒pXT1和EBO-plpp构建HBVC基因真核细胞表达载体并转染水生化B细胞,DNA分析和流式细胞仪检测HBVC基因在宿主细胞中的复制、表达。结果在转染重组质植pXT1-HBVc和EB0-plpp-HBVc的B细胞中,均能检测到目的基因;分另有89.81%和88.51%的宿主细胞能检测到HBcAg;连续培养3周后,分别有88.30%和72.19%的宿主细胞表达HBcAg。结论重组逆转录病毒表达载体pXT1-HBVc和EB病毒表达载体EBO-plpp-HBVc转染的永生化人外周血B细胞能有效地表达靶抗原(HBcAg),可作为较为理想的HBV特异性CTL作用的靶细胞。
Objective To establish target cell system of CTL response with specificity of HBV for studying the effect of CTLcytotoxicity caused by HBV gene mutation. Methods Two recombinant plasmids pXT1-HBVc and EBO-plpP-HBVc weretransferred into immortalized B cells, replication and expression of HBV C gene in the host cells were detected by DNA analysis andflow cytometry. Results DNA fragments of the same size with the goal gene can be detected in the host cells, and the expressedHBcAg was detected in 89.81 % and 88.51 % of the host cells with transfection of recombinant plasmid pXT1-HBVc and EBO-plppHBVc respectively; and in 88.30% and 72.19% after 3 weeks of culture. Conclusion The immortalized B cells transfected with therecombinant plasmid pXT1-HBVc and EBO-plpp-HBVc can expressed target antigen(HBcAg) effectively, which can serve assuitable target cells of CTL response with specifity of HBV.
出处
《第一军医大学学报》
CSCD
1999年第2期99-101,共3页
Journal of First Military Medical University
基金
国家自然科学基金